Sanders-Brown Center on Aging is now a site for the first-ever clinical trial testing the effect lecanemab has in people with no cognitive symptoms of Alzheimer’s disease but have amyloid present in their brains.
Donna Wilcock, Ph.D., was awarded a $1.7 million National Institutes of Health grant for her lab’s exploration of adverse effects of two new Alzheimer’s disease drugs shown to slow the progression of cognitive decline.
The focus of the work done by Elizabeth Rhodus, Ph.D., is to enhance sensory input in order to improve behavioral symptoms in people with Alzheimer's disease and related dementias.
The Alzheimer’s Association welcomes the University of Kentucky’s Donna M. Wilcock, Ph.D., as the new editor-in-chief of Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.
Linda J. Van Eldik, Ph.D., director of the University of Kentucky Sanders-Brown Center on Aging, is part of a $1.5 million grant to help further research into a possible treatment for Alzheimer’s disease.
David Fardo, Stephen W. Wyatt Endowed Professor in the College of Public Health, is one of 14 University Research Professors for 2022-23. He conducts research on dementia-related neuropathologies.
College of Social Work's Allison Gibson, Ph.D., is working to address a lack of information and services for people with a diagnosis of mild cognitive impairment, which often leads to dementia and Alzheimer's disease.
A researcher at the UK’s Sanders-Brown Center on Aging is one of several experts in the field who recently discussed the use of two popular screening tests for dementia and Alzheimer’s disease.
